Research progress in the molecular mechanisms, therapeutic targets, and drug development of idiopathic pulmonary fibrosis

H Ma, X Wu, Y Li, Y Xia - Frontiers in Pharmacology, 2022 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease. Recent studies have
identified the key role of crosstalk between dysregulated epithelial cells, mesenchymal …

[HTML][HTML] Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy

MKK Chan, ELY Chan, ZZ Ji, ASW Chan… - … of Targeted Anti …, 2023 - ncbi.nlm.nih.gov
Transforming growth factor-β (TGF-β) signaling is an important pathway for promoting the
pathogenesis of inflammatory diseases, including cancer. The roles of TGF-β signaling are …

ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling

J Liu, Z Wu, Y Liu, Z Zhan, L Yang, C Wang… - Journal of …, 2022 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic disease with
pathophysiological characteristics of transforming growth factor-β (TGF-β), and reactive …

Alvespimycin exhibits potential anti-TGF-β signaling in the setting of a proteasome activator in rats with bleomycin-induced pulmonary fibrosis: a promising novel …

OA Mohammed, MA Abdel-Reheim, LA Saleh… - Pharmaceuticals, 2023 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is an irreversible and life-threatening lung disease of
unknown etiology presenting only a few treatment options. TGF-β signaling orchestrates a …

[HTML][HTML] Disease modeling of pulmonary fibrosis using human pluripotent stem cell-derived alveolar organoids

T Suezawa, S Kanagaki, K Moriguchi, A Masui… - Stem Cell Reports, 2021 - cell.com
Although alveolar epithelial cells play a critical role in the pathogenesis of pulmonary
fibrosis, few practical in vitro models exist to study them. Here, we established a novel in …

The application of Aptamer in biomarker discovery

Y Li, WW Tam, Y Yu, Z Zhuo, Z Xue, C Tsang, X Qiao… - Biomarker …, 2023 - Springer
Biomarkers are detectable molecules that can reflect specific physiological states of cells,
organs, and organisms and therefore be regarded as indicators for specific diseases. And …

H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1/m6A/NREP

P Wang, D Xie, T Xiao, C Cheng, D Wang, J Sun… - Journal of Hazardous …, 2024 - Elsevier
As epigenetic modifications, lactylation and N6-methyladenosine (m6A) have attracted wide
attention. Arsenite is an environmental pollutant that has been proven to induce idiopathic …

[HTML][HTML] Fluvoxamine alleviates bleomycin-induced lung fibrosis via regulating the cGAS-STING pathway

X Xie, X Wu, D Zhao, Y Liu, Q Du, Y Li, Y Xu, Y Li… - Pharmacological …, 2023 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a fatal disease with high mortality and limited effective
therapy. Herein, we reported that fluvoxamine, a selective serotonin reuptake inhibitor …

[HTML][HTML] Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells

J Tu, H Xu, L Ma, C Li, W Qin, X Chen, M Yi, L Sun… - Theranostics, 2022 - ncbi.nlm.nih.gov
Background: Immune checkpoint inhibitors (ICIs), such as programmed cell death protein 1
(PD-1)/programmed death-ligand 1 (PD-L1), have been widely applied in clinical and …

Inhaled lipid nanoparticles alleviate established pulmonary fibrosis

D Li, A Zhao, J Zhu, C Wang, J Shen, Z Zheng, F Pan… - Small, 2023 - Wiley Online Library
Pulmonary fibrosis, a sequela of lung injury resulting from severe infection such as severe
acute respiratory syndrome‐like coronavirus (SARS‐CoV‐2) infection, is a kind of life …